Search Within

Sergio Andres Giralt

  1. "Pediatric Leukemia"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (4)
Groups
  1. Bone Marrow Transplant (13)
  2. Center for Hematologic Malignancies (13)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (13)
  4. Department of Medicine (13)
  5. GSK Faculty (13)
  6. Hematologic Malignancies, Division of (13)

More Groups

People
  1. Esperanza Papadopoulos (12)
  2. Miguel-Angel Perales (12)
  3. Nancy Kernan (12)
  4. Richard O'Reilly (12)
  5. Farid Boulad (10)
  6. Rachel Kobos (10)

More People

Years
  1. 2020 (1)
  2. 2017 (1)
  3. 2016 (2)
  4. 2015 (1)
  5. 2014 (3)
  6. 2013 (2)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (6)
  2. Blood (5)
  3. Bone Marrow Transplantation (1)
  4. Journal of Clinical Investigation (1)
Publishers
  1. Elsevier Inc. (6)
  2. American Society of Hematology (5)
  3. American Society for Clinical Investigation (1)
  4. Nature Publishing Group (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia
    Journal Article

    Getta, B. M.; Roshal, M.; Zheng, J.; Park, J. H.; Stein, E. M.; Levine, R.; Papadopoulos, E. B.; Jakubowski, A. A.; Kernan, N. A.; Steinherz, P.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplant with ablative conditioning is associated with favorable outcomes in patients with mixed phenotype acute leukemia
    Meeting Abstract

    Getta, B. M.; Zheng, J. T.; Tallman, M. S.; Park, J. H.; Stein, E. M.; Roshal, M.; Papadopoulos, E. B.; Kernan, N. A.; Steinherz, P. G.; O'Reilly, R. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Second allogeneic stem cell transplantation for acute leukemia using a chemotherapy- Only cytoreduction with clofarabine, melphalan, and thiotepa
    Journal Article

    Spitzer, B.; Perales, M. A.; Kernan, N. A.; Prockop, S. E.; Zabor, E. C.; Webb, N.; Castro-Malaspina, H.; Papadopoulos, E. B.; Young, J. W.; Scaradavou, A.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Barker, J.; Castro-Malaspina, H.; Curran, K.; Giralt, S.; Hasan, A.; Heller, G.; Hsu, K.; Jakubowski, A.; more...
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Second allogeneic stem cell transplantation for hematologic malignancies using chemotherapy only cytoreduction with clofarabine, melphalan, and thiotepa
    Meeting Abstract

    Spitzer, B.; Perales, M. A.; Kernan, N. A.; Prockop, S. E.; Webb, N.; Castro-Malaspina, H.; Papadopoulos, E. B.; Young, J. W.; Scaradavou, A.; Kobos, R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects
    Meeting Abstract

    Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Do patients with high risk or relapsed core binding factor acute myeloid leukemia benefit from salvage allogeneic stem cell transplantation?
    Meeting Abstract

    Hobbs, G.; Kishtagari, A.; Hilden, P.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E.; Devlin, S.; Boulad, F.; Kernan, N.; Kobos, R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Double-unit cord blood transplantation (DCBT) for acute leukemia: High disease-free survival in adults and children with comparable survival in European and minority patients
    Meeting Abstract

    Barker, J. N.; Ponce, D.; Devlin, S.; Lubin, M.; Evans, K.; Gonzales, A. M.; Castro-Malaspina, H.; Giralt, S. A.; Goldberg, J.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save